1Rice L. Heparin-induced thrombocytopenia: myths and misconceptions( that will cause trouble for you and your patient). Arch Intern Med, 2004, 164: 1961-1964.
2Arepally GM, Mayer IM. Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin 8. Blood, 2001, 98: 1252-1254.
3Jang IK, Hursting MJ. When heparins promote thrombosis: review of heparin-induced thrombocytopenia. Circulation, 2005, 111 : 2671-2683.
4Martel N, Lee J, Well PS. Risk for heparin-indueed thrombocytopenia with unfraetionated and low-molecular-weight heparin thromboprophylaxis : a meta-analysis. Blood, 2005, 106 : 2710-2715.
5Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest, 2004, 126: 311S-337S.
7Warkentin TE, Kehon JG. Temporal aspects of heparin-induced thrombocytopenia. N Engl J Med, 2001,344:1286-1292.
8Rice L, Attisha WK, Drexler A, et al. Delayed-onset heparin-induced thrombocytopenia. Ann Intern Med, 2002,136 : 210-215.
9Warkentin TE. Think of HIT. Hematology Am Soc Hematol Educ Program, 2006:408-414.
10Greinacher A, Farner B, Kroll H, et al. Clinical features of heparin-induced thrombocytopenia including risk factors for thrombosis. A retrospective analysis of 408 patients. Thromb Haemost, 2005,94 : 132-135.
